Contract facts
UnrestrictedNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Nitric Oxide Gas is a federal Unrestricted award for 246-Network Contracting Office 6 (36C246) held by Ino Therapeutics LLC. Estimated value $738K ($270K obligated). Current period of performance ends Dec 31, 2026 (potential Dec 31, 2027). Last award drew 2 bidders. Place of performance: BEDMINSTER NJ. Related solicitation 36C24623Q0068.
Nitric oxide gas. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (75 days remaining). Agencies typically plan 12–18 months ahead — at 2.5 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C24623C0012? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordIno Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24623C0012?
36C24623C0012 (Nitric oxide gas) is a 246-Network Contracting Office 6 (36C246) award with a potential value of $738K, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C246-23-C-0012?
36C246-23-C-0012 is the dashed form of PIID 36C24623C0012 (Nitric oxide gas), held by Ino Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24623C0012?
246-Network Contracting Office 6 (36C246) awarded 36C24623C0012 to Ino Therapeutics LLC (potential $738K).
Who is the incumbent on 36C24623C0012?
Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Ino Therapeutics LLC’s 36C24623C0012 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24623C0012? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.